✦ LIBER ✦

Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132

✍ Scribed by Dian Wang; Qiang Zhang; Charles D. Blanke; George D. Demetri; Michael C. Heinrich; James C. Watson; John P. Hoffman; Scott Okuno; John M. Kane; Margaret von Mehren; Burton L. Eisenberg

Book ID: 115031696
Publisher: Springer
Year: 2011
Tongue: English
Weight: 507 KB
Volume: 19
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-011-2190-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Phase II Trial of Neoadjuvan

Erratum to: Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132

✍ Wang, Dian; Zhang, Qiang; Blanke, Charles D.; Demetri, George D.; Heinrich, Mich 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 153 KB

Phase II trial of neoadjuvant/adjuvant i

Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665

✍ Burton L. Eisenberg; Jonathan Harris; Charles D. Blanke; George D. Demetri; Mich 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB